Authors:Mirzabey N. Rustamov

Belarusian State Medical University, Minsk, Belarus Iasi, Romania, 8th of November 2019

DOI: 10.52338/jjogastro.2024.4023

Abstract

“The doctor of the future will no longer treat the human frame with drugs, but rather will cure and prevent disease with nutrition.” - Thomas Edison

BACKGROUND
The triple treatment including PPI-clarithromycin and amoxicillin or metronidazole proposed at the first Maastricht conference to treat H.pylori infection has become universal since it was recommended by all the consensus conferences held around the world. However, the most recent data show that this combination has lost some efficacy and often allows the cure of only a maximum of 70% of the patients, which is less than the 80% rate aimed for at the beginning and far below what should be expected for an infectious disease. While no new drug has been developed for this indication, a number of studies have been carried out in recent years using different combinations of known antibiotics.

Citation:

Mirzabey N. Rustamov. Epidemiology of IBS in Belarus Japanese Journal of Gastroenterology 2022.